AK Steel Holding Corp (AKS) 6.24 $AKS The Zacks Analyst

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
AK Steel Holding Corp (AKS) 6.24 $AKS

The Zacks Analyst Blog Highlights: AK Steel Holding, Tempur Sealy International, Seagate Technology, OMNOVA Solutions and MaxLinear
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:30AM CDT
The Zacks Analyst Blog Highlights: AK Steel Holding, Tempur Sealy International, Seagate Technology, OMNOVA Solutions and MaxLinear
OMN: 9.11 (+0.09), TPX: 76.76 (+0.52), STX: 30.73 (+0.08), MXL: 21.32 (-0.10), AKS: 6.24 (+0.12)

Bull of the Day: Arcelor Mittal (MT)
Jeremy Mullin - ZACKS - Tue Aug 02, 6:00AM CDT
Bull of the Day: Arcelor Mittal (MT)
STLD: 26.53 (+0.15), NUE: 53.43 (+0.43), SLX: 31.69 (+0.67), AKS: 6.24 (+0.12), X: 26.27 (+0.58), MT: 6.21 (+0.10)

AK Steel (AKS) Q2 Earnings Beat Estimates, Sales Trail
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 3:43PM CDT
AK Steel Holding Corporation (AKS) reported net income of $17.3 million or 8 cents per share in second-quarter 2016, as against a net loss of $64 million or 36 cents per share in the year-ago quarter.
RYI: 14.50 (+0.56), SCHN: 19.00 (-0.03), AKS: 6.24 (+0.12), MT: 6.21 (+0.10)

5 Best Top Ranked Stocks of July
Swarup Gupta - Zacks Investment Research - Mon Aug 01, 10:49AM CDT
Markets enjoyed a month of strong gains on the back of a modest increase in earnings numbers and impressive economic data.
AMZN: 753.35 (-7.23), F: 12.12 (+0.18), OMN: 9.11 (+0.09), BLK: 368.06 (+0.98), STX: 30.73 (+0.08), C: 43.79 (+0.80), MXL: 21.32 (-0.10), AKS: 6.24 (+0.12), WFC: 47.52 (-0.18), BAC: 14.43 (+0.30), MS: 28.47 (+0.47), GS: 158.70 (+2.64), JPM: 64.45 (+0.80), TPX: 76.76 (+0.52), PNC: 83.70 (+2.04), MSFT: 56.71 (+0.13), AAPL: 105.74 (+1.26)

AK Steel Holding (AKS) Catches Eye: Stock Jumps 8.4%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:00AM CDT
AK Steel Holding Corporation (AKS) was a big mover last session, as the company saw its shares rise over 8% on the day.
RYI: 14.50 (+0.56), AKS: 6.24 (+0.12)

Zacks Investment Ideas feature highlights: World Fuel Services, AKS Steel, Anadarko Petroleum, General Dynamics and Simon Property
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 8:30AM CDT
Zacks Investment Ideas feature highlights: World Fuel Services, AKS Steel, Anadarko Petroleum, General Dynamics and Simon Property
GD: 147.27 (-0.95), SPG: 221.42 (-2.19), INT: 45.88 (+0.47), AKS: 6.24 (+0.12), APC: 52.45 (+0.82)

Can AK Steel (AKS) Run Higher on Strong Earnings Estimate Revisions?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 8:18AM CDT
AK Steel (AKS) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
AKS: 6.24 (+0.12)

Nucor (NUE) Q2: Will Its Earnings Beat on Improved Pricing?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:40PM CDT
Nucor (NUE) is gearing up to release its second-quarter 2016 results ahead of the bell on Jul 21.
STLD: 26.53 (+0.15), RYI: 14.50 (+0.56), NUE: 53.43 (+0.43), AKS: 6.24 (+0.12)

Can Reliance Steel (RS) Maintain Its Earnings Streak in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:30PM CDT
Reliance Steel (RS) is set to release its second-quarter 2016 results before the opening bell on Jul 21.
STLD: 26.53 (+0.15), RS: 76.90 (-0.29), RYI: 14.50 (+0.56), AKS: 6.24 (+0.12)

AK Steel's (AKS) Shares Touch Fresh 52-Week High at $5.52
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:40AM CDT
Shares of AK Steel (AKS) touched a new 52-week high of $5.52 on Jul 13.
ZEUS: 23.92 (+1.91), SCHN: 19.00 (-0.03), AKS: 6.24 (+0.12), MT: 6.21 (+0.10)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of AK Steel Holding Corporation - AKS
ACCESSWIRE - Tue Jul 12, 4:02PM CDT
NEW YORK, NY / ACCESSWIRE / July 12, 2016 / Levi & Korsinsky announces it has commenced an investigation of AK Steel Holding Corporation (NYSE: AKS) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to:
AKS: 6.24 (+0.12)

U.S. Stainless Steel Sheet and Strip Industry Encouraged by Commerce Department's Affirmative Preliminary Determination in China Subsidy Investigation
PR Newswire - Tue Jul 12, 1:25PM CDT
Today, the U.S. Department of Commerce announced its preliminary determination that imports of stainless steel sheet and strip ("SSSS" from China are benefitting from unfair government subsidies. As a result, it will instruct U.S. Customs and Border Protection ("CBP" to begin to require U.S. importers of SSSS from China to deposit estimated countervailing duties at the time of importation. Further, based on its previously announced preliminary affirmative critical circumstances determination, the Commerce Department will instruct CBP to suspend liquidation of all entries of SSSS from China that were imported into the United States on or after the date that is 90 days prior the date of publication in the Federal Register of the affirmative preliminary countervailing duty determination, and to require U.S. importers to post security equal to the preliminary subsidy rates on those entries.
ATI: 17.88 (+0.85), AKS: 6.24 (+0.12)

Alcoa Earnings Beat Sparks Hope; Buy These 5 Material Stocks
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 10:59AM CDT
The earnings beat from Alcoa and improved outlook for the basic materials sector make it a good space to invest in.
STLD: 26.53 (+0.15), AA: 10.39 (+0.07), ABX: 22.48 (-0.21), NUE: 53.43 (+0.43), AKS: 6.24 (+0.12), SCL: 64.60 (+0.42)

The Zacks Analyst Blog Highlights: AK Steel, Gulfport Energy, Hecla Mining, Carrizo Oil & Gas and Xencor
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 8:30AM CDT
The Zacks Analyst Blog Highlights: AK Steel, Gulfport Energy, Hecla Mining, Carrizo Oil & Gas and Xencor
HL: 6.44 (-0.11), AKS: 6.24 (+0.12), CRZO: 31.80 (+1.24), XNCR: 20.86 (+1.58), GPOR: 28.53 (+0.64)

LB Foster (FSTR) Continues to Underperform: Time to Sell it?
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:42PM CDT
On Jul 11, 2016, we issued an updated research report on premium railroads manufacturing firm LB Foster Co. (FSTR).
GGB: 2.36 (+0.11), FSTR: 10.75 (+0.68), AKS: 6.24 (+0.12), MT: 6.21 (+0.10)

5 Growth Stocks Poised for Huge Earnings Beats
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 2:31PM CDT
These 5 stocks look poised to post huge earnings beats in the coming season, and have great growth metrics as well.
HL: 6.44 (-0.11), AKS: 6.24 (+0.12), CRZO: 31.80 (+1.24), XNCR: 20.86 (+1.58), GPOR: 28.53 (+0.64)

Think Beyond Precious Metals: 6 Basic Materials Stocks To Buy
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 10:12AM CDT
We suggest that investors look beyond precious metals and invest in these six growth stocks in the basic material space.
TSE: 50.81 (+1.39), RYI: 14.50 (+0.56), AXLL: 32.78 (+0.02), AKS: 6.24 (+0.12), FSI: 1.60 (+0.02), KOP: 30.45 (+0.38)

Monsanto and DuPont Sign Multi-Year Herbicide Supply Deal
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:07AM CDT
Monsanto Company and DuPont have inked a multi-year supply deal in Canada and the United States for the weed destroyer, dicamba.
BG: 64.14 (+0.81), MON: 106.05 (+0.43), DD: 69.10 (+0.37), AKS: 6.24 (+0.12)

Why AK Steel Holding (AKS) Might Be a Diamond in the Rough
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 7:35AM CDT
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is AK Steel Holding Corporation (AKS)
AKS: 6.24 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading